Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| ARK Investment Management | 2.4M | $1.3M | 279% | Jun 2026 |
|
| Springbok Capital Management | 321k | $177k | 42% | Jun 2026 |
|
| Bank of America Corporation | 193k | $106k | 48% | Jun 2026 |
|
| Two Sigma Investments | 184k | $101k | 26% | Jun 2026 |
|
| Susquehanna International | 158k | $87k | 1428% | Jun 2026 |
|
| Persistent Asset Partners | 148k | $81k | 100% | Jun 2026 |
|
| Renaissance Technologies | 134k | $74k | 4% | Jun 2026 |
|
| Geode Capital Management | 130k | $71k | 61% | Jun 2026 |
|
| Jpmorgan Chase & Co | 121k | $70k | 100% | Jun 2026 |
|
| Simplex Trading | 111k | $61k | 4160% | Jun 2026 |
|
| Winton Capital | 99k | $55k | 100% | Jun 2026 |
|
| Morgan Stanley | 98k | $92k | -51% | Mar 2026 |
|
| Goldman Sachs Group | 89k | $49k | -12% | Jun 2026 |
|
| Citadel Advisors | 88k | $49k | 70% | Jun 2026 |
|
| UBS Group | 74k | $41k | -47% | Jun 2026 |
|
| Hrt Financial | 50k | $27k | 100% | Jun 2026 |
|
| Jane Street | 41k | $23k | 100% | Jun 2026 |
|
| XTX Topco | 22k | $12k | -78% | Jun 2026 |
|
| Chico Wealth RIA | 16k | $8.7k | 100% | Jun 2026 |
|
| SkyView Investment Advisors | 10k | $9.0k | 0% | Mar 2026 |
|
| Mcguire Capital Advisors | 2.5k | $1.4k | 0% | Jun 2026 |
|
| Group One Trading | 1.0k | $572.995800 | 403% | Jun 2026 |
|
| Activest Wealth Management | 1.0k | $550.000000 | 0% | Jun 2026 |
|
| Steward Partners Investment Advisory | 500.00 | $275.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 402.00 | $221.019600 | -66% | Jun 2026 |
|
| Wells Fargo & Company | 200.00 | $110.000000 | -98% | Jun 2026 |
|
| Red Tortoise | 150.00 | $139.995000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Diametric Capital | Mar 2026 | 1.5M | $1.4M |
| Invesco | Mar 2026 | 62k | $57k |
| Virtu Financial | Mar 2026 | 43k | $40k |
| Two Sigma Securities | Mar 2026 | 20k | $19k |
| Prosperity Consulting Group | Mar 2026 | 18k | $16k |
| Harbour Investments | Mar 2026 | 16k | $15k |
| Millennium Management | Mar 2026 | 12k | $11k |
| Neuberger Berman Group | Mar 2026 | 11k | $10k |
| Tower Research Capital | Mar 2026 | 2.9k | $2.7k |
| SRS Capital Advisors | Mar 2026 | 1.0k | $944.965000 |
| TD Waterhouse Canada | Mar 2026 | 150.00 | $144.000000 |